Gland Pharma names Shyamakant Giri as new CEO MD Bureau19 Oct 2024 3:29 PM ISTNew Delhi: Gland Pharma has announced a major leadership change with the appointment of Shyamakant Giri as the new Chief Executive Officer (CEO),...
NPPA fixes price for various FDCs having Sitagliptin, Linagliptin Ruchika Sharma7 Feb 2024 6:00 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs...
Abbott India profit rises in Q3 on strong demand Ruchika Sharma2 Feb 2024 10:00 AM ISTBengaluru: Pharmaceutical firm Abbott India reported a 26 percent rise in third-quarter profit on Thursday, as higher sales outpaced the impact...
CDSCO Panel Tells Abbott India to revise phase IV CT protocol of Dydrogesterone plus Estradiol Tablets Dr. Divya Colin24 Sept 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has opined the drug major Abbott...
Popular antacid Digene gel receives warning alert from DCGI, Abbott initiates recall Roshni Dhar8 Sept 2023 10:34 AM ISTThe popular antacid Digene gel has received a warning alert from the Drugs Control General of India (DCGI) following which batches of the product have...
Conduct Bioequivalence Study: CDSCO panel tells Abbott India on Dydrogesterone MR Tablets Dr. Divya Colin6 Aug 2023 6:00 PM ISTNew Delhi: Responding to the proposal for manufacturing and marketing synthetic progesterone, Dydrogesterone Modified-release (MR) Tablets presented...
Health Bulletin 13/June/2023 Isra Zaman13 Jun 2023 4:29 PM ISTHere are the top health stories for the day:Why can't medical college reports be made public? Transparency woes plague NMCWhile the apex medical...
Monitor endometrioma size of clinical trial participants: CDSCO panel tells Abbott India on Dydrogesterone Dr. Divya Colin12 Jun 2023 6:00 PM ISTNew Delhi: Suggesting monitoring the size of the endometrioma of participating subjects during the clinical trial, the Subject Expert Committee (SEC)...
HC relief to Abbott India, allows Rs 48 crore spent on gifts to doctors in 2008-09 to be claimed as expense Farhat Nasim16 Feb 2023 7:21 PM ISTMumbai: In respite to drug maker Abbott India Ltd., the Bombay High Court has ruled that the CBDT Circular issued in 2012 as per which the expenses...
Continued pricing pressures in US, European Markets to affect profit margins of Indian pharma firms: Ratings agency ICRA Ruchika Sharma6 Jan 2023 2:30 PM ISTICRA said most major Indian pharmaceutical companies continue to focus on emerging markets to fuel their growth, given that they continue to face...
Include more govt sites for Phase III clinical trial of Ursodeoxycholic Acid Tablets: CDSCO panel to Abbott MD Bureau28 Feb 2021 11:15 AM ISTNew Delhi: Suggesting to include more government sites in Phase III Clinical trial protocol, the Central Drugs Standard Control Organization (CDSCO)...
Vikas Multicorp to enter Pharma, Healthcare business, gets nod to acquire Advik Labs Ruchika Sharma15 Jan 2021 12:53 PM ISTMumbai: BSE and NSE listed Vikas Multicorp Ltd. had recently announced the outcome of its Board meeting held on 12 January 2021.Vikas Multicorp Ltd....
